Provided by Tiger Trade Technology Pte. Ltd.

BRII-B

0.850
-0.020-2.30%
Volume:22.00K
Turnover:18.75K
Market Cap:613.70M
PE:-2.35
High:0.855
Open:0.855
Low:0.850
Close:0.870
52wk High:2.330
52wk Low:0.830
Shares:722.00M
HK Float Shares:722.00M
Volume Ratio:0.41
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.361
ROE:-7.67%
ROA:-7.02%
PB:0.24
PE(LYR):-2.35
PS:15.04

Loading ...

HK Movers | Biotech Stocks Jump. Asymchem up Nearly 7%; SKB Bio up About 6%; Hengrui Pharma, Pharmaron, InnoGen up over 4%; Wuxi Apptec up 3%; Laekna, Joinn, Remegen up over 2%

Tiger Newspress
·
Jun 05

Brii Bio says Phase 2 ENSURE trial shows higher HBV functional cure rate with elebsiran plus pegylated interferon alfa

Reuters
·
May 27

BRII-B (02137) and Vir Yet to Settle Claims in Ongoing Dispute

Stock News
·
May 22

BRII-B Initiates Arbitration Against Vir Biotechnology, Casting Uncertainty Over Elebsiran Hepatitis B Program

Bulletin Express
·
May 22

Brii Biosciences Ltd - as of May 22, Arbitration Between Brii and Vir Remains in Early Stages With No Resolution

THOMSON REUTERS
·
May 22

Brii Biosciences Ltd - Considers Elebsiran Program Future Uncertain Due to Ongoing Dispute

THOMSON REUTERS
·
May 22

Brii Biosciences - Cannot Invest in Phase 3 Clinical Study of Any Elebsiran-Containing Combination Therapy for Hbv Until Claims Are Resolved

THOMSON REUTERS
·
May 22

Brii Biosciences says arbitration with Vir clouds elebsiran hepatitis B program future

Reuters
·
May 22

Biotech Stocks Plunge Amid Global Bond Selloff and Rising Interest Rate Concerns

Stock News
·
May 18

HK Movers | Biotech Stocks Jump. InnoGen up over 44%; Clover Bio up over 11%; Junshi Bio up 9%; Laekna up 8%; Asymchem up over 3%; Tigermed up 2%

Tiger Newspress
·
May 11

Brii Biosciences Issues 47,409 New Shares in April; Public Float Remains Above 25% Threshold

Bulletin Express
·
May 06

HK Movers | Biotech Stocks Jump. Wuxi Apptec Soars 14% as 1Q Net Profit Rises 26.7%; Junshi Bio up 8%; Asymchem up Nearly 7%; Pharmaron up 4%

Tiger Newspress
·
Apr 28

BRII-B (02137) Presents Cross-Study Analysis on HBsAg Rebound Post-Treatment at APASL 2026

Stock News
·
Apr 26

Brii Biosciences presents post-treatment HBsAg rebound analysis at APASL 2026

Reuters
·
Apr 26

Brii Biosciences Schedules 16 June 2026 Virtual AGM; Agenda Covers Director Re-elections, Deloitte Re-appointment and 20% Share Issuance Mandate

Bulletin Express
·
Apr 23

BRII-B publishes 2025 Annual Report, ESG Report and AGM documents online; shareholders offered flexible receipt options

Bulletin Express
·
Apr 23

BRII-B Schedules 16 Jun 2026 Virtual AGM; Seeks Approval for 2025 Accounts, Board Re-election and 20% Issuance Mandate

Bulletin Express
·
Apr 23

Brii-Bio to Hold Virtual AGM on 16 June 2026; Targets 20% Issuance Mandate, 10% Buy-Back and Director Re-elections

Bulletin Express
·
Apr 23

Brii Biosciences publishes 2025 annual report

Reuters
·
Apr 23

Brii Biosciences announces annual general meeting via Vistra eVoting Portal

Reuters
·
Apr 23